Read news on ERBB2 with our app.
Read more in the app
Unveiling new targets in LAR triple-negative breast cancer: ERBB2 mutations and senescence - EurekAlert!
Racial and ethnic disparities in receipt of ERBB2-targeted therapy for breast cancer - EurekAlert!
